Valeant to Name New CEO as Pearson Hospitalized, WSJ Says

Updated on
  • Schiller, Rosiello may be candidates, newspaper says
  • Pearson remains on medical leave for severe pneumonia

Michael Pearson.

Photographer: Scott Eells/Bloomberg

Valeant Pharmaceuticals International Inc. will name a new chief executive officer to lead the company while Michael Pearson remains hospitalized after contracting severe pneumonia, the Wall Street Journal reported Tuesday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.